The relatively modest changes in t-tau levels in ADC, as compared to Alzheimer's disease, may relate to the predominating subcortical pathology of ADC/HIVE [54], since tau is expressed most prominently in non-myelinated cortical axons [55]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.